Skip to main content
SpringerLink
Log in

Evaluation of Coronary Artery Patency Using Cardiac Markers

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The availability of a reliable marker of infarct-related artery (IRA) patency status may permit early identification of patients with patent IRA, for whom repeat thrombolysis or rescue percutaneous coronary intervention (PCI) may not be necessary. We found that the ratio of serum myoglobin levels obtained before and 60-min after initation of thrombolytic therapy provides a useful indication of the IRA patency status. When the 60-min myoglobin ratio was >4.0, the probability of a patent IRA was 90%, suggesting that emergency coronary angiography to determine their IRA status may be unnecessary when this pattern of release of myoglobin is observed. The low specificity of this marker could be addressed by its combined use with other noninvasive tests such as ST-segment resolution and the persistence of chest pain at the time of angiography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AMI:

acute myocardial infarction; CK, Creatine Kinase; CK-MB, creatine-kinase-MB; cTnI, cardiac Troponin-I; ECG, electrocardiogram; IRA, infarct-related artery; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction; TNK-tPA, TNK-tissue plasminogen activator.

References

  1. GRUPPO ITALIANO PER LO STUDIO DELLA STREPTOCHINASI NELL’INFARTO MIOCARDICO (GISSI): Effectiveness of Intravenous Thrombolytic Treatment in Acute Myocardial Infarction. Lancet 1986;I:397–401.

    Google Scholar 

  2. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349–360.

    Google Scholar 

  3. The Gusto Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–682.

    Google Scholar 

  4. Braunwald E. The open-artery theory is alive and well—again. N Engl J Med 1993;329:1650–1652.

    Article  CAS  PubMed  Google Scholar 

  5. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615–1622.

    Google Scholar 

  6. Cannon CP, McCabe CH, Diver DJ, et al., Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infraction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial. TIMI 4 Investigators. J Am Coll Cardiol 1994;24:1602–1610.

    CAS  PubMed  Google Scholar 

  7. Kircher BJ, Topol EJ, O’Neill WW, Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol 1987;59:513–515).

    Article  CAS  PubMed  Google Scholar 

  8. Califf RM, O’Neil W, Stack RS, et al., Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Int Med 1988;108:658–662.

    CAS  PubMed  Google Scholar 

  9. Garabedian HD, Gold HK, Yasuda T, et al., Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: Correlation with acute angiography. J Am Coll Cardiol 1988;11:729–734.

    CAS  PubMed  Google Scholar 

  10. Lewis BS, Ganz W, Laramee P, et al. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1988;62:20–24.

    Article  CAS  PubMed  Google Scholar 

  11. Ohman EM, Christenson RH, Califf RM, et al. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Am Heart J 1993;126:819–826.

    Article  CAS  PubMed  Google Scholar 

  12. Tanasijevic MJ, Cannon CP, Wybenga DR, et al. for the TIMI 10A Investigators. Myoglobin, CK-MB and cardiac Troponin-I for non-invasive assessment of reperfusion after thrombolysis for acute myocardial infarction. Results from TIMI 10A. Am Heart J 1997;134:622–630.

    CAS  PubMed  Google Scholar 

  13. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44–49.

    CAS  PubMed  Google Scholar 

  14. Ellis AK, Little T, Masud AR, Klocke FJ. Patterns of myoglobin release after reperfusion of injured myocardium. Circulation 1985;72:639–647.

    CAS  PubMed  Google Scholar 

  15. Ellis AK, Little T, Masud AR, Liberman HA, Morris DC, Klocke FJ. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. Circulation 1988;78:1352–1357.

    CAS  PubMed  Google Scholar 

  16. Ishii J, Nomura M, Ando T, et al. Early detection of successful coronary reperfusion based on serum myoglobin concentration: Comparison with serum creatine kinase isoenzyme MB activity. Am Heart J 1994;128:641–648.

    Article  CAS  PubMed  Google Scholar 

  17. Tanasijevic MJ, Cannon CP, Antman EM, et al. Myoglobin, creatine-kinase-MB and cardiac Troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: Results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. J Am Coll Cardiol 1999;34:739–747.

    Article  CAS  PubMed  Google Scholar 

  18. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler . Intracellular compartmentation of cardiac Troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360–1367.

    Article  CAS  PubMed  Google Scholar 

  19. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and Troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542–1550.

    CAS  PubMed  Google Scholar 

  20. Remppis A, Scheffold T, Karrer O, et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac Troponin T measurements in serum. Br Heart J 1994;71:242–248.

    CAS  PubMed  Google Scholar 

  21. Apple FS, Voss E, Lund L, Preese L, Berger CR, Henry TD. Cardiac Troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy. Clin Chim Acta 1995;237:59–66.

    Article  CAS  PubMed  Google Scholar 

  22. Puleo PR, Perryman MB, Bresser MA, Rokey R, Pratt CM, Roberts R. Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man. Circulation 1987;75:1162–1169.

    CAS  PubMed  Google Scholar 

  23. Christenson RH, Ohman EM, Topol EJ, et al. Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group. Clin Chem 1995;41:844–852.

    CAS  PubMed  Google Scholar 

  24. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac Troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996;105:6–10.

    CAS  PubMed  Google Scholar 

  25. Katus HA, Diederich KW, Scheffold T, Uellner M, Schwarz F, Kubler W. Non-invasive assessment of infarct reperfusion: The predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. Eur Heart J 1988;9:619–624.

    CAS  PubMed  Google Scholar 

  26. Laperche T, Steg PG, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Circulation 1995;92:2079–2086.

    CAS  Google Scholar 

  27. de Lemos J, Morrow D, Gibson CM, et al. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol 2001;88:353–358.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Laboratories Division, Department of Pathology, Brigham and Women’s Hospital, Boston, MA, 02115, USA

    Milenko J. Tanasijevic MD

Authors
  1. Milenko J. Tanasijevic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Milenko J. Tanasijevic MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanasijevic, M.J. Evaluation of Coronary Artery Patency Using Cardiac Markers. J Thromb Thrombolysis 19, 21–24 (2005). https://doi.org/10.1007/s11239-005-0936-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-005-0936-2

Search

Navigation